ConductScience.org, home

Paper33336364

Physicochemical properties of dihydromyricetin and the effects of ascorbic acid on its stability and bioavailability.

Sun CC and 3 others. J Sci Food Agric, 2021. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. Physicochemical properties of dihydromyricetin and the effects of ascorbic acid on its stability and bioavailability. Papers, record 33336364. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33336364

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Physicochemical properties of dihydromyricetin and the effects of ascorbic acid on its stability and bioavailability.
PubMed
Journal
J Sci Food Agric
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
2.23
iCite
Revised in PubMed
2021-07-20
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sun CCCui-Cui
2Li YYing
3Yin ZPZhong-Ping
4Zhang QFQing-Fenghttps://orcid.org/0000-0002-1277-042X

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Ascorbic AcidMajor topic
FlavonolsMajor topic
Animals
Biological Availability
Chromatography, High Pressure Liquid
Drug Stability
Female
Kinetics
Rats
Rats, Sprague-Dawley
Solubility

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
31760461National Natural Science Foundation of ChinaPubMed

Source PubMed

Download CSV of grants

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
42625354Review of the Composition and Antimicrobial Roles of Extracts of Vine Tea (Ampelopsis grossedentata).Med Sci Monit2026https://conductscience.org/library/papers/42625354PubMed
41792133The natural flavonoid dihydromyricetin targets senescent cells via PRDX2 and alleviates age-related diseases.Nat Commun2026https://conductscience.org/library/papers/41792133PubMed
41398910Development and evaluation of a novel nebulized dihydromyricetin formulation: enhanced pulmonary delivery and pharmacokinetic properties.Respir Res2025https://conductscience.org/library/papers/41398910PubMed
40757164A multifunctional dihydromyricetin-loaded hydrogel for the sequential modulation of diabetic wound healing and glycemic control.Burns Trauma2025https://conductscience.org/library/papers/40757164PubMed
40740995Pharmacological mechanisms and potential clinical applications of Dihydromyricetin in neurological disorders.Front Pharmacol2025https://conductscience.org/library/papers/40740995PubMed
40538991Orange-Fleshed Sweet Potatoes, Grain Amaranth, Biofortified Beans, and Maize Composite Flour Formulation Optimization and Product Characterization.Food Sci Nutr2025https://conductscience.org/library/papers/40538991PubMed
40076792Molecular Mechanism of Vine Tea Dihydromyricetin Extract on Alleviating Glucolipid Metabolism Disorder in db/db Mice: Based on Liver RNA-Seq and TLR4/MyD88/NF-κB Pathway.Int J Mol Sci2025https://conductscience.org/library/papers/40076792PubMed
39227809Dihydromyricetin suppresses endothelial NLRP3 inflammasome activation and attenuates atherogenesis by promoting mitophagy.Lipids Health Dis2024https://conductscience.org/library/papers/39227809PubMed
39206852Design, synthesis, and biological activity evaluation of dihydromyricetin derivatives against SARS-CoV-2-Omicron virus.J Enzyme Inhib Med Chem2024https://conductscience.org/library/papers/39206852PubMed
38628627Multiple molecular and cellular mechanisms of the antitumour effect of dihydromyricetin (Review).Biomed Rep2024https://conductscience.org/library/papers/38628627PubMed
36618100Structure-activity relationship of dietary flavonoids on pancreatic lipase.Curr Res Food Sci2023https://conductscience.org/library/papers/36618100PubMed
36146939Strategic developments in the drug delivery of natural product dihydromyricetin: applications, prospects, and challenges.Drug Deliv2022https://conductscience.org/library/papers/36146939PubMed
35312865Curdlan production from cassava starch hydrolysates by Agrobacterium sp. DH-2.Bioprocess Biosyst Eng2022https://conductscience.org/library/papers/35312865PubMed
35154679LC-ESI-QTOF/MS characterization of antimicrobial compounds with their action mode extracted from vine tea (Ampelopsis grossedentata) leaves.Food Sci Nutr2022https://conductscience.org/library/papers/35154679PubMed
35115939Mechanism of Dihydromyricetin on Inflammatory Diseases.Front Pharmacol2021https://conductscience.org/library/papers/35115939PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33336364

GET https://conductscience.org/api/papers/v1/33336364/authors